This compound is a pharmaceutical intermediate featuring a complex structure with multiple aromatic rings and halogen substituents. It is used in the synthesis of active pharmaceutical ingredients.
Escopo do conteúdo: As informações desta página dizem respeito à identificação química e aos contextos de fornecimento industrial, pesquisa e produção. Não constituem alegação terapêutica, aconselhamento médico ou instruções de uso de medicamentos.
Adquirindo ou fornecendo este composto?
Publique seu inventário ou uma solicitação de compra
CAS 877399-51-4
Crizotinib
active pharmaceutical ingredient
(S)-crizotinib
active pharmaceutical ingredient
Tert-butyl 4-(4-iodo-1H-pyrazol-1-yl)piperidine-1-carboxylate
Pharmaceutical intermediate for drug synthesis
Tert-butyl 4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)piperidine-1-carboxylate
Pharmaceutical intermediate for synthesis
2,5-Pyridinedicarboxylic acid, 1,6-dihydro-6-oxo-, 2-ethyl ester
Pharmaceutical intermediate
Methyl 2-bromo-4-methylbenzoate
Pharmaceutical intermediate for synthetic chemistry
tert-butyl 4-[4-[6-amino-5-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-3-pyridinyl]pyrazol-1-yl]piperidine-1-carboxylate
QDGJKKNXEBCNJI-OAHLLOKOSA-N
C[C@H](C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCN(CC4)C(=O)OC(C)(C)C)N